BridgeMD
New treatment option for AAA
Official title JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
ClinicalTrials.gov ID: NCT05064540
What this study is testing
- What it's testing
- Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 and older
You may be able to join if
- Adult age 21 and older
- people with minimum of 2 year life expectancy
- people have signed the informed consent document
- people with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the...
- Patient must be able and willing to comply with all required follow-up exams.
You likely can't join if
- Currently participating in another trial where the primary endpoint has not been reached yet.
- Known allergy to any of the device components
- Pregnant (females of childbearing potential only)
- Known connective tissue disorders
- Known active infection
- people with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR.
See the full eligibility criteria
- Adult age 21 and older
- people with minimum of 2 year life expectancy
- people have signed the informed consent document
- people with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices.
- Patient must be able and willing to comply with all required follow-up exams.
- Currently participating in another trial where the primary endpoint has not been reached yet.
- Known allergy to any of the device components
- Pregnant (females of childbearing potential only)
- Known connective tissue disorders
- Known active infection
- people with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR.
- Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.
The study team makes the final eligibility decision.
Where it's taking place
- Huntsville, Alabama, United States
- Tucson, Arizona, United States
- Fayetteville, Arkansas, United States
- Little Rock, Arkansas, United States
- La Jolla, California, United States
- San Diego, California, United States
- Washington D.C., District of Columbia, United States
- Jacksonville, Florida, United States
- Lakeland, Florida, United States
- Miami, Florida, United States
- Iowa City, Iowa, United States
- Louisville, Kentucky, United States
- Boston, Massachusetts, United States
- Detroit, Michigan, United States
- Columbia, Missouri, United States
- Newark, New Jersey, United States
- New York, New York, United States
- Staten Island, New York, United States
- Cleveland, Ohio, United States
- Columbus, Ohio, United States
+ 8 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntsville, Alabama, United States; Tucson, Arizona, United States; Fayetteville, Arkansas, United States; Little Rock, Arkansas, United States; La Jolla, California, United States; San Diego, California, United States and 22 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.